These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3281723)

  • 1. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67.
    Grogan TM; Lippman SM; Spier CM; Slymen DJ; Rybski JA; Rangel CS; Richter LC; Miller TP
    Blood; 1988 Apr; 71(4):1157-60. PubMed ID: 3281723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
    Yamanaka N; Harabuchi Y; Kataura A
    Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.
    Bevilacqua P; Verderio P; Barbareschi M; Bonoldi E; Boracchi P; Dalla Palma P; Gasparini G
    Breast Cancer Res Treat; 1996; 37(2):123-33. PubMed ID: 8750580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.
    Miller TP; Grogan TM; Dahlberg S; Spier CM; Braziel RM; Banks PM; Foucar K; Kjeldsberg CR; Levy N; Nathwani BN
    Blood; 1994 Mar; 83(6):1460-6. PubMed ID: 8123837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
    Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
    Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype.
    Lippman SM; Miller TP; Spier CM; Slymen DJ; Grogan TM
    Blood; 1988 Aug; 72(2):436-41. PubMed ID: 3261181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
    Offit K; Ladanyi M; Gangi MD; Ebrahim SA; Filippa D; Chaganti RS
    Leukemia; 1990 Sep; 4(9):625-30. PubMed ID: 2168505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells.
    Jovanović MP; Jaković L; Bogdanović A; Marković O; Martinović VC; Mihaljević B
    Vojnosanit Pregl; 2009 Sep; 66(9):738-43. PubMed ID: 19877554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.
    Ansell SM; Kurtin PJ; Stenson M; Habermann TM; Greipp PR; Therneau TM; Witzig TE
    Leuk Lymphoma; 1999 Aug; 34(5-6):529-37. PubMed ID: 10492076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases.
    Chott A; Kaserer K; Augustin I; Vesely M; Heinz R; Oehlinger W; Hanak H; Radaszkiewicz T
    Am J Surg Pathol; 1990 May; 14(5):439-48. PubMed ID: 2158242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.
    Kreipe H; Alm P; Olsson H; Hauberg M; Fischer L; Parwaresch R
    Am J Pathol; 1993 Feb; 142(2):651-7. PubMed ID: 8094598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
    Cordone I; Matutes E; Catovsky D
    Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM; Maisano C; Scibilia J
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
    Richendollar BG; Pohlman B; Elson P; Hsi ED
    Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of Ki67 antigen using MIB1 antibody as a prognostic factor in renal pelvic and ureteral cancer].
    Kojima K; Naruo S; Kanayama H; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1996 May; 87(5):822-30. PubMed ID: 8691707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma.
    Romaguera JE; Manning JT; Tornos CS; Rodriguez J; Brooks TE; Pugh WC; Ordonez NG; Goodacre AM; Cabanillas F
    Ann Oncol; 1994 Apr; 5(4):317-22. PubMed ID: 8075027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of immunologic phenotype in diffuse large cell lymphoma.
    Horning SJ; Doggett RS; Warnke RA; Dorfman RF; Cox RS; Levy R
    Blood; 1984 May; 63(5):1209-15. PubMed ID: 6370335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.